These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 69049)

  • 41. Influence of lipids and obesity on haemorheological parameters in patients with deep vein thrombosis.
    Vayá A; Falcó C; Simó M; Ferrando F; Mira Y; Todolí J; España F; Corella D
    Thromb Haemost; 2007 Sep; 98(3):621-6. PubMed ID: 17849051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Quantitation of cholesterol levels in HDL subfractions (author's transl)].
    Irie N; Yano Y; Homma Y; Hara T; Takeuchi I; Nakaya N; Goto Y
    Nihon Ronen Igakkai Zasshi; 1980 Nov; 17(6):587-94. PubMed ID: 7206297
    [No Abstract]   [Full Text] [Related]  

  • 44. [HDL cholesterol: clinical and pathobiochemical aspects (author's transl)].
    Assmann G; Schriewer H; Oberwittler W
    Klin Wochenschr; 1980 Aug; 58(15):757-65. PubMed ID: 7003233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Blood lipid disorders and their significance].
    Forster G
    Praxis; 1968 Sep; 57(36):1219. PubMed ID: 5696028
    [No Abstract]   [Full Text] [Related]  

  • 46. [Dislipoproteinemias as risk factors in cardiovascular diseases: study in patients with chronic ischemic heart disease (author's transl)].
    Camejo G; Acquatella H; Lalaguna F; Hirschhaut E; Guinand Baldó A; Burger B; Pérez Rojas M; Aparicio JM; Suárez JA; Pérez Padrón J
    Acta Cient Venez; 1977; 28(1):77-81. PubMed ID: 865780
    [No Abstract]   [Full Text] [Related]  

  • 47. [Dyslipemia and coronary insufficiency in women (author's transl)].
    Gichtenaere JC; Jullien G; Fredenucci P; Gerard R
    Ann Cardiol Angeiol (Paris); 1977 Oct; 26(5):373-6. PubMed ID: 907300
    [No Abstract]   [Full Text] [Related]  

  • 48. Plasma viscosity increase with progression of peripheral arterial atherosclerotic disease.
    Poredos P; Zizek B
    Angiology; 1996 Mar; 47(3):253-9. PubMed ID: 8638868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease.
    Steiner G; Schwartz L; Shumak S; Poapst M
    Circulation; 1987 Jan; 75(1):124-30. PubMed ID: 3791598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Screening and therapy control of lipid metabolism disturbances in general practice (author's transl)].
    Assmann G; Schriewer H
    MMW Munch Med Wochenschr; 1980 Mar; 122(13):449-52. PubMed ID: 6769013
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Lipid constellation in low density lipoproteins of primary type II hyperlipoproteinemia (author's transl)].
    Haacke H; Parwaresch MR; Mäder C
    Klin Wochenschr; 1975 Dec; 53(23):1121-4. PubMed ID: 173916
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Agargel and immune electrophoretic investigations about the interaction of the stuff dye with the plasma proteins (author's transl)].
    Wulf E; Jurkiewicz B; Schmidt J
    Acta Histochem; 1974; 48(2):208-21. PubMed ID: 4136291
    [No Abstract]   [Full Text] [Related]  

  • 53. Contribution of fibrinogen and lipoproteins to plasma viscosity in hypercholesterolemia and hypertriglyceridemia: evaluation by selective depletion of low-density lipoproteins or fibrinogen.
    Otto C; Richter WO; Schwandt P
    Metabolism; 2000 Jun; 49(6):810-3. PubMed ID: 10877212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyperlipidemia, lipoproteins and coronary disease.
    Olsson AG
    Acta Cardiol; 1974; Suppl 20():37-45. PubMed ID: 4548621
    [No Abstract]   [Full Text] [Related]  

  • 55. [Alterations in blood- and plasma-viscosity of patients with risk-factors (author's transl)].
    Leonhardt H; Uthoff A; Stelter I
    Med Klin; 1975 Dec; 70(49):1997-2000. PubMed ID: 1207634
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prevalence of cardiovascular risk factors in coronary heart disease patients with different low-density lipoprotein phenotypes].
    Slapikas R; Luksiene D; Slapikiene B; Babarskiene MR; Grybauskiene R; Linoniene L
    Medicina (Kaunas); 2005; 41(11):925-31. PubMed ID: 16333215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
    Ravindran R; Krishnan LK
    Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Typology of the hyperlipoproteinemias in ischemic heart disease].
    Zakharova VN; Afanas'eva ON; Andrushchenko ES; Naumova LV; Zarudina IN
    Kardiologiia; 1977 Dec; 17(12):105-8. PubMed ID: 202776
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The importance of type IV hyperlipoproteinemia as a predisposing factor in coronary artery disease.
    Salel AF; Riggs K; Mason DT; Amsterdam EA; Zelis R
    Am J Med; 1974 Dec; 57(6):897-903. PubMed ID: 4378395
    [No Abstract]   [Full Text] [Related]  

  • 60. [The LDL-HDL ratio in patients with coronary arteriosclerosis (author's transl)].
    Zimmer F; Riebeling V; Benke B; Schuster J; Roskamm H
    Z Kardiol; 1980 Mar; 69(3):149-53. PubMed ID: 7456590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.